Author(s): Neetu, Shailendra Kumar, Anshika Garg

Email(s): anshikacreations03@gmail.com

DOI: 10.52711/2321-5836.2025.00017   

Address: Neetu1, Shailendra Kumar2, Anshika Garg3
1R.V. Northland Institute, Dadri, Greater Noida, Uttar Pradesh, India.
2JMS Pharmacy College, Ghaziabad, Uttar Pradesh, India.
3Sanskar College of Pharmacy and Research, Ghaziabad, 201302, Uttar Pradesh, India.
*Corresponding Author

Published In:   Volume - 17,      Issue - 2,     Year - 2025


ABSTRACT:
For patients suffering from end-stage renal disease (ESRD) and chronic kidney disease (CKD), cardiovascular disease (CVD) is a major source of morbidity and mortality. This population's CV risk is greatly increased by the interaction of non-traditional risk factors like inflammation, oxidative stress, and aberrant calcium-phosphate levels with classic risk factors like diabetes, hypertension, and dyslipidemia. Early detection and care are crucial since the prevalence of CV problems increases significantly as CKD advances to ESRD. Results have frequently been less than ideal despite efforts to reduce CV risk using standard therapies and dialysis techniques, especially because of the intricate relationships that exist between traditional risk factors and malnutrition in CKD patients. Nutritional control, especially with renal diets, is essential for controlling CV risk factors since it treats proteinuria, insulin resistance, anemia, hypertension, and dyslipidemia. Certain dietary strategies, such as the high-protein, high-phosphorus keto diet, have demonstrated potential to improve CV outcomes by postponing the start of dialysis and maintaining residual renal function.


Cite this article:
Neetu, Shailendra Kumar, Anshika Garg. Interplay between Renal Dysfunction and Cardiovascular Complications: A Focus on Myocardial Infarction and Dietary Approaches. Research Journal of Pharmacology and Pharmacodynamics.2025;17(2):107-1. doi: 10.52711/2321-5836.2025.00017

Cite(Electronic):
Neetu, Shailendra Kumar, Anshika Garg. Interplay between Renal Dysfunction and Cardiovascular Complications: A Focus on Myocardial Infarction and Dietary Approaches. Research Journal of Pharmacology and Pharmacodynamics.2025;17(2):107-1. doi: 10.52711/2321-5836.2025.00017   Available on: https://rjppd.org/AbstractView.aspx?PID=2025-17-2-4


REFERENCES:
1.    Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? Journal of the American College of Cardiology. 2006 Jan 3; 47(1):1-8.
2.    Gottlieb S. Study quantifies dangers of renal disease after heart attack. BMJ. 2004 Sep 23; 329(7468): 702.
3.    Davenport MS, Perazella MA, Nallamothu BK. Contrast-induced acute kidney injury and cardiovascular imaging: danger or distraction? Circulation. 2023 Mar 14; 147(11): 847-9.
4.    Locatelli F, Bommer J, London GM, Martín‐Malo A, Wanner C, Yaqoob M, Zoccali C. Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. Nephrology Dialysis Transplantation. 2001 Mar 1; 16(3):459-68.
5.    Foley RN. Clinical epidemiology of cardiovascular disease in chronic kidney disease. Journal of renal care. 2010 May; 36:4-8.
6.    S. Raghavi, V.G. Karthigeyan, S. Prabhu. Protective Effect of Plectranthus amboinicus Leaf Extract Containing Luteolin Flavanoid in Isoproterenol Hydrochloride Induced Myocardial Infarction in Rats - An Assessment on Biochemical and Cellular Changes. Research J. Engineering and Tech. 2013; 4(4):   195-198.
7.    Saiprasanna Behera, S. Manohar Babu, Y Roja Ramani, Prasanta Kumar Choudhury, Rajeshree Panigrahi. Cardioprotective Activity of Ocimum canum Hydro-alcoholic Leaf Extracts Against Isoproterenol Induced Myocardial Infarction in Rats. Research J. Pharmacology and Pharmacodynamics. 2012; 4(4): 191-201.
8.    Preeti Tiwari, Rakesh K Patel. Cardioprotective activity of Ashwagandharishta on Isoproterenol Induced Myocardial Infarction. Research J. Pharmacology and Pharmacodynamics. 2012; 4(5): 294-298.
9.    Preeti Tiwari. Cardioprotective Activity of Amritarishta on Isoproterenol Induced Myocardial Infarction. Research J. Pharmacology and Pharmacodynamics. 2013; 5(6): 356-361.
10.    S. Renuka, Gowri Sethu. Regeneration after Myocardial Infarction. Research J. Pharm. and Tech. 2015; 8(6):  738-741.
11.    Hardik Joshi, Manoj Pagare, Leena Patil, Vilasrao Kadam. Cardioprotective Effect of Ethanolic Extract of Buchanania lanzan Spreng. Against Isoproterenol Induced Myocardial Infarction in Rats: A Biochemical, Electrocardiographic Evaluation. Research J. Pharm. and Tech. 2012; 5(2): 263-266.
12.    S. Sarumathy, T. S. Shanmugarajan, K. G. Suresh Rao, N. Benazeer Begum. Significance of Clinical Laboratory Values as early indicators of Myocardial Infarction - A Retrospective Study. Research J. Pharm. and Tech. 2018; 11(4): 1563-1565.
13.    Hasitha Diana Manohar, Srinivasan D, Sengottuvelu S. Cardioprotective activity of Limonia acidissima against Isoproterenol Induced Myocardial Infarction in Rats. Research J. Pharm. and Tech. 2016; 9(5): 541-544.
14.    Gulnara Bedelbayeva, Zhannat Nurmakhanova, Murat Almukhambetov, Nazima Zarubekova, Ainur Nuftieva. Factors of the Complicated Course of the Myocardial Infarction in Men and Women. Research J. Pharm. and Tech. 2018; 11(5): 1737-1744.
15.    J. S. Karnewar, V. K. Shandilya. Myocardial Infarction Detection using Morphological Features of ECG Signal. Research Journal of Pharmacy and Technology. 2023; 16(6):2921-6.
16.    Sörnmo L, Laguna P. Electrocardiogram (ECG) signal processing. Wiley encyclopedia of biomedical engineering. 2006 Apr 14.
17.    Shen L, Shah BR, Nam A, Holmes D, Alexander KP, Bhatt DL, Ho PM, Peterson ED, He B, Roe MT. Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction. American Heart Journal. 2014 Jun 1; 167(6): 840-5.
18.    Valensi P, Lorgis L, Cottin Y. Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature. Archives of Cardiovascular Diseases. 2011 Mar 1; 104(3): 178-88.
19.    Cupisti A, Aparicio M, Barsotti G. Potential benefits of renal diets on cardiovascular risk factors in chronic kidney disease patients. Renal Failure. 2007 Jan 1; 29(5): 529-34.
20.    Vaskonen T. Dietary minerals and modification of cardiovascular risk factors. The Journal of Nutritional Biochemistry. 2003 Sep 1; 14(9): 492-506.
21.    Appel LJ. The effects of dietary factors on blood pressure. Cardiology Clinics. 2017 May 1; 35(2): 197-212.
22.    Ferraro PM, Bargagli M, Trinchieri A, Gambaro G. Risk of kidney stones: influence of dietary factors, dietary patterns, and vegetarian–vegan diets. Nutrients. 2020 Mar 15;12(3):779.
23.    McCarron DA. Dietary sodium and cardiovascular and renal disease risk factors: dark horse or phantom entry? Nephrology Dialysis Transplantation. 2008 Jul 1; 23(7): 2133-7.

Recomonded Articles:

Author(s): K. Rashid, C. Senthil Kumar, P. M. Mohammed Haleel

DOI: 10.5958/2321-5836.2017.00037.4         Access: Open Access Read More

Author(s): Madhavi Sahu, S. Prakash Rao

DOI: 10.5958/2321-5836.2018.00031.9         Access: Open Access Read More

Author(s): VI Zalavadiya, VK Shah, DD Santani, MS Patel, JM Fosi, AK Chaudhary.

DOI: Not Available         Access: Open Access Read More

Author(s): Mahesh Babasaheb Kolap, Nandini Maruti Bhise, Nisha Vasant Poojary, Rajesh Keshav Bhadke

DOI: Research Journal of Pharmacology and Pharmacodynamics 2023;15(1):6-8.         Access: Open Access Read More

Author(s): Upadhyay SU, Jain VC, Upadhyay UM.

DOI: 10.5958/2321-5836.2015.00021.X         Access: Open Access Read More

Author(s): Lubna Azmi, Shyam Sundar Gupta, Ila Shukla, Padam Kant, O. P. Sidhu, Ch. V. Rao

DOI: 10.5958/2321-5836.2017.00001.5         Access: Open Access Read More

Author(s): Satish Narra, Bandenawaz Ramadurg, Saraswathi C D.

DOI: Not Available         Access: Open Access Read More

Author(s): Ajay Saxena, Pravin Kumar Rai, Ajay Kumar Meena, Anupam Srivastava, Priyanka Pandey, Kiran Shrivastava, Shikha Sharma , Gyanendra Dutt Shukla.

DOI: Not Available         Access: Open Access Read More

Author(s): Kanase KG, Shinde NV, Bharti DK, Undale VR, Bhosale AV.

DOI: Not Available         Access: Open Access Read More

Author(s): Madhavi T, Soosammajohn, Khambhoja S, Bincy Raj, Amit Kumar.

DOI: Not Available         Access: Open Access Read More

Author(s): Pallavi B. Jire, Mayuri V. Khairnar, Mayuri V. Mali, Sulbha G. Patil

DOI: 10.52711/2321-5836.2023.00024         Access: Open Access Read More

Author(s): Gharge Deepali, Bavaskar Sunil, Todkar Pavan,Dhabale Pandurang.

DOI: Not Available         Access: Open Access Read More

Author(s): Rohit Gundamaraju Diana Vivian Atigari, DS Helen Sheeba, Ramesh C.

DOI: Not Available         Access: Open Access Read More

Author(s): Shoaib Ahmad

DOI: 10.5958/2321-5836.2017.00017.9         Access: Open Access Read More

Author(s): Prasad K, Nitin M, Chetan M, Girish M, Krishna Kumar.

DOI: Not Available         Access: Open Access Read More

Author(s): Namrata Dwivedi, Bhavna Dwivedi, Skand Mishra, Yogeshwer Shukla.

DOI: Not Available         Access: Open Access Read More

Research Journal of Pharmacology and Pharmacodynamics (RJPPD) is an international, peer-reviewed journal....... Read more >>>

RNI: Not Available                     
DOI: 10.5958 2321-5836 

Journal Policies & Information




Recent Articles




Tags